Skip to main content
Signal8

David Glenn

SEC insider (Form 3/4/5 filer). CIK 0001606256. Chief Financial Officer at PHIBRO ANIMAL HEALTH CORP (PAHC). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in TEANECK, NJ.

Companies David Glenn has filed insider reports for

  • PHIBRO ANIMAL HEALTH CORP (PAHC): Officer, Chief Financial Officer
David Glenn profile photo

David Glenn

CIK: 0001606256

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PHIBRO ANIMAL HEALTH CORP logo
PAHC

PHIBRO ANIMAL HEALTH CORP

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • PHIBRO ANIMAL HEALTH CORP logo
    PAHC

    PHIBRO ANIMAL HEALTH CORP

    Aug 6, 2026
    Award
    Direct
    3.5K shares-
  • PHIBRO ANIMAL HEALTH CORP logo
    PAHC

    PHIBRO ANIMAL HEALTH CORP

    Aug 4, 2026
    Other
    Direct
    840 shares at avg. $36.60$31K
  • PHIBRO ANIMAL HEALTH CORP logo
    PAHC

    PHIBRO ANIMAL HEALTH CORP

    Feb 11, 2026
    Other
    Direct
    12.5K shares at avg. $51.63$647K
  • PHIBRO ANIMAL HEALTH CORP logo
    PAHC

    PHIBRO ANIMAL HEALTH CORP

    Feb 9, 2026
    Exercise
    Direct
    30K shares-
  • PHIBRO ANIMAL HEALTH CORP logo
    PAHC

    PHIBRO ANIMAL HEALTH CORP

    Aug 15, 2025
    Award
    Direct
    4.8K shares-
  • PHIBRO ANIMAL HEALTH CORP logo
    PAHC

    PHIBRO ANIMAL HEALTH CORP

    Feb 9, 2025
    Exercise
    Direct
    30K shares-

1-6 of 6